Skip to main content
Centenial Surgical Suture Ltd. logo

Centenial Surgical Suture Ltd. — Investor Relations & Filings

Ticker · 531380 ISIN · INE405H01018 LEI · 335800S4BG17LDGSD515 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-23 Regulatory Filings
Country IN India
Listing BSE.NS 531380

About Centenial Surgical Suture Ltd.

https://centenialindia.com/

Centenial Surgical Suture Ltd. specializes in the development and manufacture of a diverse range of surgical sutures and wound management solutions. The product portfolio encompasses both absorbable and non-absorbable sutures, including materials such as polyglycolic acid, polydioxanone, silk, polyester, and polypropylene. The company also produces precision-engineered surgical needles and specialized meshes designed for various clinical applications. Adhering to rigorous quality management systems, the organization focuses on delivering high-performance medical consumables that ensure effective wound closure and patient safety. Its offerings serve a global network of hospitals, surgical clinics, and specialized medical practitioners, emphasizing technical reliability and clinical efficacy in surgical procedures.

Recent filings

Filing Released Lang Actions
Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1) To approve Standalone ....
Regulatory Filings Classification · 86% confidence The document is an intimation of a Board meeting under SEBI LODR Regulation 29/33 to approve audited financial results. It is a regulatory announcement scheduling a board meeting rather than the report itself, containing no financial data or changes in board composition. This fits under a general regulatory filing (RNS) rather than a full report, earnings release, or management change.
2026-05-23 English
PFA
Regulatory Filings Classification · 80% confidence The document is a formal letter from Centenial Surgical Suture Ltd. to BSE Limited’s Surveillance/Investigation Department explaining and requesting an investigation into unusual price movements in its shares. It includes annexures detailing trading activity but does not contain financial statements or management commentary on results. It is a compliance disclosure under listing regulations rather than a financial report, earnings release, management presentation, or corporate action notice. It therefore falls into the fallback category for general regulatory announcements and compliance filings.
2026-05-11 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.